El‑Haggar, S. M., Hegazy, S. K., Abd-Elsalam, S. M., & Bahaa, M. M. (2022). Pentoxifylline, a nonselective phosphodiesterase inhibitor, in adjunctive therapy in patients with irritable bowel syndrome treated with mebeverine. Elsevier.
Chicago Style (17th ed.) CitationEl‑Haggar, Sahar M., Sahar K. Hegazy, Sherief M. Abd-Elsalam, and Mostafa M. Bahaa. Pentoxifylline, a Nonselective Phosphodiesterase Inhibitor, in Adjunctive Therapy in Patients with Irritable Bowel Syndrome Treated with Mebeverine. Elsevier, 2022.
MLA (8th ed.) CitationEl‑Haggar, Sahar M., et al. Pentoxifylline, a Nonselective Phosphodiesterase Inhibitor, in Adjunctive Therapy in Patients with Irritable Bowel Syndrome Treated with Mebeverine. Elsevier, 2022.
Warning: These citations may not always be 100% accurate.